Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133651) titled 'Long-term outcomes of endoscopic ultrasound-guided lauromacrogol ablation versus pancreatic surgery for pancreatic cystic neoplasms' on Sept. 30.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Chinese PLA General Hospital

Condition: pancreatic cystic neoplasms

Intervention: EUS-lauromacrogol ablation group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-30

Target Sample Size: EUS-lauromacrogol ablation group:100;surgery group:300;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=324464 ...